ID
22440
Description
ODM derived from http://clinicaltrials.gov/show/NCT00185393
Link
http://clinicaltrials.gov/show/NCT00185393
Keywords
Versions (2)
- 12/9/11 12/9/11 -
- 6/4/17 6/4/17 - Martin Dugas
Uploaded on
June 4, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
Eligibility
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
other anticancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0478584
Description
Prior radiation therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0279134
Description
no recovery from chemotherapy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1709277
- UMLS CUI [1,2]
- C0392920
Description
other cancer
Data type
boolean
Alias
- UMLS CUI [1]
- C1707251
Description
HIV
Data type
boolean
Alias
- UMLS CUI [1]
- C0019682
Description
pleural effusion or ascites
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032227
- UMLS CUI [1,2]
- C0003962
Description
pregnant or breast feeding
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Description
no contraception
Data type
boolean
Alias
- UMLS CUI [1]
- C2919192
Description
non-compliance
Data type
boolean
Alias
- UMLS CUI [1]
- C0457432
Similar models
Eligibility
- StudyEvent: Eligibility
C0280116 (UMLS CUI [1,2])
C0280117 (UMLS CUI [1,3])
C2045825 (UMLS CUI [1,2])
C1442456 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
C0003962 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])